Pfizer's Zoetis (ZTS) May be Largest IPO Since Facebook (FB)
Tweet
Share
E-mailGet Alerts ZTS Hot Sheet
Up)Join SI Premium – FREE
Eyes are on focus for the biggest IPO to hit the U.S. since Facebook(Nasdaq: FB).
Bloomberg notes today that Pfizer's animal health spin-off, Zoetis, Inc. (NYSE: ZTS), will unload 86.1 million shares today with an expected range of $22 to $25 apiece. That gives Zoetis an initial market cap of $11.8 billion at the midpoint.
Zoetis would be the largest, publicly-traded animal health-focused company, competing with the likes of Sanofi-Aventis (NYSE: SNY), Lilly (NYSE: LLY), and Merck & Co. (NYSE: MRK).
Pfizer is only selling about 17 percent of the company in the offering. Sales for Zoetis were $4.3 billion in 2012, giving it about 20 percent of the total animal health market.
As a reminder, Facebook raised $16 billion when it IPO'd on May 18, 2012. Those following the stock knew what happened shortly after, with shares plummeting to below $20 in the following weeks. Zoetis may be the reverse of that; despite being a market leader with tangible profit, global food demand will bolster sector growth by about 6 percent annually over the next three years. One analyst from Huntington even sees Zoetis being a potential takeover target.
No time has been given on when the IPO will commence. Pfizer shares are lower in early trading Thursday.
Bloomberg notes today that Pfizer's animal health spin-off, Zoetis, Inc. (NYSE: ZTS), will unload 86.1 million shares today with an expected range of $22 to $25 apiece. That gives Zoetis an initial market cap of $11.8 billion at the midpoint.
Zoetis would be the largest, publicly-traded animal health-focused company, competing with the likes of Sanofi-Aventis (NYSE: SNY), Lilly (NYSE: LLY), and Merck & Co. (NYSE: MRK).
Pfizer is only selling about 17 percent of the company in the offering. Sales for Zoetis were $4.3 billion in 2012, giving it about 20 percent of the total animal health market.
As a reminder, Facebook raised $16 billion when it IPO'd on May 18, 2012. Those following the stock knew what happened shortly after, with shares plummeting to below $20 in the following weeks. Zoetis may be the reverse of that; despite being a market leader with tangible profit, global food demand will bolster sector growth by about 6 percent annually over the next three years. One analyst from Huntington even sees Zoetis being a potential takeover target.
No time has been given on when the IPO will commence. Pfizer shares are lower in early trading Thursday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation – ZTS
- Zoetis Inc. (ZTS) PT Lowered to $195 at Piper Sandler
- Travel firm Viking aims for up to $10.8 billion valuation in US IPO
Create E-mail Alert Related Categories
IPOs, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
